IndraLab

Statements


Mutated KRAS activates JOSD2. 2 / 2
| 2

reach
"KRAS mutants significantly upregulate JOSD2 by inhibiting the E3 ligase activity of CHIP."

reach
"Moreover, KRAS mutants remarkably upregulated the protein levels and prolonged the half-life of JOSD2-WT, while posed little effect on JOSD2-3KR, demonstrating KRAS mutants regulating JOSD2 levels and stability mainly through K48, K142, and K181 (Fig. 4j)."